The cannabis industry set a record in its spending on Washington lobbying last year, with its outlay of $5.43 million.
That’s according to an analysis of disclosures by OpenSecrets, which rounded up data from 20 top industry players, including companies such as Canopy Growth Corp. CGC, -3.07% and Cronos Group Inc. CRON, -2.01% and trade associations like the National Cannabis Roundtable.
The 2022 lobbying spending came in just slightly above the prior record level of $5.22 million for 2021.
Last year outlays to influence policymakers and regulators were made as the industry had hits and misses in Washington, D.C.
Read more at marketwatch.com